January 2024

January 24, 2024

Approximately 70 percent of medical decisions are based on pathology and laboratory test results. Studies have shown, however, that 10 to 30 percent of the estimated 13 billion tests performed in the United States each year are either unnecessary or inappropriate. This over-testing leads to wasted cost and added hardship for the patient, who may also undergo excessive treatment as a result of inappropriate testing.

Health systems that are taking action to reduce the amount of unnecessary and inappropriate laboratory testing are saving millions of dollars.

Cleveland Clinic saved $5.9 million over eight years by avoiding more than 209,000 unnecessary tests. They were able to achieve these savings through automated notifications at the point of ordering. Their efforts included hard stop alerts to block repeat orders for tests that are never needed more than once in 24 hours and soft stop alerts that notify the provider when they are attempting to place a duplicate order and showing the previous results.

The University of Virginia Health System realized an annual savings of $61,524 on C. difficile testing alone after implementing a computerized clinical decision support (CCDS) tool to help clinicians determine the right time to order the right test. An internal audit prior to use of the tool showed that up to 67 percent of hospital-onset C. difficile infection cases did not have an indication for C. difficile testing.

Test Utilization is key to reducing costs

Between out-of-control healthcare spending and pressure to combat staff and supply shortages, health system labs need a simple way to reduce unnecessary, outdated, high-cost, low-value test orders.

The savings that can be realized through implementing an effective utilization program can more than compensate for the expense of putting the appropriate resources and team in place. Estimates project that healthcare systems could reduce costs of up to $5 billion per year if they were just to eliminate redundant tests.

Eliminate wasteful testing with hc1 Test Utilization™

Leveraging usage data and automated decision support greatly reduces unnecessary test orders and costs. However, data siloed across disconnected systems that don’t communicate well with one another can make test utilization improvement efforts a laborious and time-consuming process that lab leaders don’t have the resources to manage.

hc1’s Test Utilization™ combines a comprehensive, customizable utilization engine with real-time insights to help labs reduce unnecessary, outdated, high-cost and low-cost value test orders. With a view into where and how often specific types of misutilization are occurring, lab leaders can target change across their organization and lower costs.

A few key features of hc1 Test Utilization that put the control in the hands of lab decision-makers are

Shift from historical practice to best practice

Start from a core set of testing guidelines based on Choosing Wisely® recommendations, then customize them to fit your needs.

Ability to monitor utilization trends in real time

Uncover where and how often misutilization occurs to identify room for improvement and take targeted action.

Target and track the highest-cost testing

See which rules, types of rules, providers and locations are responsible for the most spending on unnecessary testing.

Driving change across your organization

Gain a clear view of ordering patterns throughout your organization, target change and monitor ordering behavior over time.

See how we can help you eliminate wasteful testing

Request a demo to see how hc1 Test Utilization can help your lab and health system save money!

_______________________________________________________________________

Lauren VanDenBoom, vice president of marketing at hc1 Insights, leads hc1’s marketing team in their efforts to advance awareness of hc1’s unique capabilities and vision. Lauren’s background includes more than 18 years of lab industry marketing and communications, including key marketing roles in toxicology and women’s health-focused laboratories.

January 10, 2024

Healthcare organizations – especially laboratories – continue to experience rising costs year over year. These costs are driven by various factors, primarily staffing shortages, supply chain issues, increasing test complexity and general market forces like inflation.

How can labs combat these rising costs and ensure their operations don’t fall behind? Below are three strategies that can set labs up for success in 2024.

Reduce labor costs by optimizing staffing levels

Labor accounts for nearly half of health systems’ budgets and, according to the American Hospital Association, has increased more than 20 percent since 2019. Clinical labor costs are projected to grow 6 to 10 percent in 2023-24, about three to seven percentage points above the prevailing rate of inflation.

Further exacerbating the problem is the growing shortage of laboratory personnel. This shortage is due to several factors, including high educational costs; lack of familiarity with laboratory medicine as a career option, declines in the number of training programs and students trained; and high workload, stress and burnout.

One innovative way to both reduce turnover due to burnout and reduce costs associated with understaffing is to ensure lab staff scheduling is as efficient as possible. This can be done by predicting likely specimen volume in each department and then adjusting staffing levels accordingly.

hc1 Workforce Optimization, our new cloud-based technology solution, uses artificial intelligence (AI) and machine learning (ML) trained on combined lab testing and HRIS data to recommend the most likely scheduling adjustments to create maximum efficiency. These actionable recommendations enable lab leaders to precisely schedule staff according to anticipated volume, reducing reliance on costly sendouts and travel techs.

Utilize excess analyzer capacity by bringing new testing in-house

Molecular and other advanced testing types firmly established a foothold in laboratories in response to the COVID-19 pandemic. Now that the value of PCR testing for infectious diseases has been widely recognized, laboratories are increasingly expected to expand the scope of their existing testing capabilities to include more analytes and observations.

A 2022 survey by Medical Laboratory Observer uncovered that 54 percent of lab professionals had excess capacity in analyzers originally purchased to handle COVID-19 testing. This number is expected to continue increasing as at-home COVID-19 testing becomes the norm.

In response, 46 percent of those with excess capacity said they planned to add new tests to in-house offerings from among those that are currently sent out to reference labs, compared to just 10 percent that said they would retire some analyzers. Utilizing this excess capacity is a great way to draw more value from these capital investments while lowering the lab’s cost per test for tests brought in-house.

But how do labs determine which tests to bring in-house and what the financial impact will be? hc1 Sendout Management is an analytics tool that consolidates reference lab data into a single dashboard to provide real-time insight into reference lab performance and cost. With this data in hand, labs can assess specific sendout tests and make informed decisions based on reference lab performance and cost.

Improve laboratory stewardship to reduce wasteful testing

Improving laboratory stewardship will be key for value-based health systems in 2024. Leveraging usage data and automated decision support is proving to be highly successful in reducing unnecessary test orders and costs. The savings that can be realized through implementing an effective utilization program can more than makeup for the expense of putting the appropriate resources and team in place to do so. Estimates project that healthcare systems could reduce costs up to $5 billion per year if they were just to eliminate redundant tests.

One large, midwestern health system utilized hc1 PrecisionDx Advisor to launch a test utilization program across 12 hospitals, driving measurable, positive change. With real-time visibility and a clear focus for initial improvement, this health system was able to quickly compare utilization trends by site location, physician and several other attributes to bring issues and opportunities to light. Substantial reductions in the utilization rates of individual analytes at the hospital level were achieved within 15 months.

Ultimately, the system-wide impact of these efforts was a 5.6% reduction in lab tests per patient per day, which amounted to 147,000 fewer unnecessary tests per year and a conservative cost savings of $383,000.

As laboratories look to address rising costs and other significant challenges facing the industry in 2024, hc1 is here to help. Our unique technology solutions help labs leverage their data to deliver superior outcomes. Request a demo today to discuss how we can work together to lower your lab’s costs and set your organization up for success this year.

_____________________________________________________________________________

Mackin Bannon is the product marketing manager for hc1. Mackin held various roles covering nearly every marketing area before settling on product marketing as a focus and joining hc1 in 2022. During the workday, he enjoys bringing stories to life in clear and creative ways. In his free time, he enjoys following his favorite sports teams, collecting vinyl records and exploring Indianapolis.